Health news you can trust
The Bloomberg School of Public Health’s weekly news feature shares timely, relevant health information of interest to a wide audience. It draws on the expertise of our faculty, physicians and staff to highlight key public health topics and developments.
As the year comes to a close, this week’s medical headlines include:
A new vaccine for the deadly tick-borne disease Lyme disease is showing promise. It is the first vaccine to target the bacteria responsible for the illness.
The opioid crisis is affecting all age groups and communities. But millennials are the most affected, with more seeking treatment and more seeking help. Dr. Nathan Wood and the panel discuss the epidemic, what can be done about it and how to get help.
It’s easy to find misinformation on the internet, but experts suggest you stick with government sources such as the Centers for Disease Control and Prevention or sites associated with medical organizations for well-vetted information. Plus, a CDC advisory panel votes to recommend only flu vaccines without the preservative thimerosal.
NIH’s long-held standard for peer review has been subverted by a top NIH official. NIH’s chief of policy and strategy joins the conversation to discuss the ramifications and how they may affect future research.